New Jersey, Feb 08, 2022 – Freyr, one of the largest, global, Regulatory-focused solutions and services companies for the Life Sciences industry, announced the successful completion of 10 years in business. With very humble beginnings back in 2011, Freyr has exponentially grown into Regulatory services & solutions powerhouse with over 1200+ Regulatory experts, 950+ Global clients and regional presence across 17 global locations.
Over the course of a decade, Freyr has dramatically expanded its Regulatory offerings across all the business segments, such as Pharmaceuticals, Biologics / Vaccines, Generics, Medical Devices, Consumer Healthcare, Cosmetics, Food and Food Supplements, Chemicals, etc. Started as a technology service provider, Freyr eventually forayed into multiple Regulatory offerings ranging from consulting, outsourcing, digital, staffing, including end-to-end Regulatory lifecycle product ownership services. Freyr has set up dedicated Centers of Excellence (CoE) across the entire Regulatory value-chain, including ancillary functions like Pharmacovigilance, and each of these CoEs have grown from strength-to-strength over the past decade.
Freyr has grown to be a trusted Regulatory partner to 950+ global customers, including 8 of the Global Top 10 Drugs and Biotechnology Companies, 4 of the Top 10 Med Tech and Healthcare Equipment and services companies, 2 of the Global Leading COVID Vaccine companies, 4 of the Global Top 10 Household & Personal Products Companies, and 2 of the Top 10 Food & Drinks Companies, and 100s of Mid-market $1+ Billion BioPharma, and Several Small and Medium, Fast Growing Life Sciences companies, CROs, and Standards Agencies.
In recent years, Freyr has progressively evolved its technology offerings (‘Freyr Digital’) to provide industry-leading Digital Transformation solutions focused on Regulatory and other areas like Pharmacovigilance, using AI, ML, and RPA technologies.
Freyr has also significantly increased its local, in-country Regulatory Affairs expertise in 15+ global markets like China, Japan, Canada, Australia, UK, Germany, France, Switzerland, UAE, Mexico, Singapore, Malaysia, South Africa, Slovenia, Sri Lanka, Poland and continues to add more in-country Regulatory expertise in other regions.
Reflecting on the exponential growth over the last decade, Freyr leadership team has sincerely expressed that this journey wouldn’t have been possible without the passionate support and trust from the employees, customers, and partner ecosystem.
Stepping into the next decade, Freyr envisions radically revolutionizing the entire Regulatory services and solutions landscape. In line with the growing demand for innovation-driven solutions and services Freyr will continue to channelize its investments in increasing the expert Regulatory teams and infrastructure, scaling-up in-country presence in more global markets, and in building sustainable client partnerships.
Know More about Freyr's Journey, here.
Freyr is one of the largest, global, Regulatory-focused solutions and services companies for the Life Sciences industry supporting, Large, Medium and Small Size Global Life sciences companies (Pharmaceutical | Generics | Medical Device | Biotechnology | Biosimilar | Consumer Healthcare | Cosmetics) in their entire Regulatory value-chain, ranging from Regulatory Strategy, Intelligence, Dossiers, Submissions, etc. to Post- Approval/Legacy Product Maintenance, Labeling, Artwork Change Management, and other related functions.
Headquartered in New Jersey, USA, Freyr has regional offices across the UK, Germany, France, Switzerland, UAE, Canada, Mexico, Singapore, Malaysia, South Africa, Slovenia, Sri Lanka, Australia, Poland, China, and has a Global Delivery Center in Hyderabad, India.
- 950+ global customers and growing
- 1200+ in-house Regulatory experts
- 900+ in-country Regulatory affiliates across 120+ countries
- ISO 9001 Certified for strong process and quality management
- ISO 27001 Certified for information security management, state-of-the-art infrastructure